Regulators push Amgen to withdraw drug due to data manipulation

STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more

Amgen's PCSK9 Patent Battle: Legal Loss but Commercial Victory

This article examines Amgen's legal battle over PCSK9 cholesterol drugs, specifically their patent dispute with Sanofi and Regeneron. Amgen

FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company

The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ

FDA halts release of new drug rejection letters while working to formalize policy

STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug

Federal jury rules against Prevagen maker in deceptive marketing case over unsubstantiated memory claims

A federal jury has handed down a verdict in the deceptive marketing case against Prevagen's maker, Quincy Bioscience. The case, brought by t